Clincosm LogoSign in Get a demo

B Cell Lymphoma

Showing 26 - 47 of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, B Cell Lymphoma Trial in Wuhan (Second generation humanized CAR-T cells)

Recruiting
  • Acute Lymphoblastic Leukemia
  • B Cell Lymphoma
  • Second generation humanized CAR-T cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 5, 2019

B Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Wuhan (Third generation CAR-T cells)

Recruiting
  • B Cell Lymphoma
  • Acute Lymphoblastic Leukemia
  • Third generation CAR-T cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 5, 2019

B Cell Lymphoma Trial in Shanghai (CD20-directed CAR-T cells)

Unknown status
  • B Cell Lymphoma
  • CD20-directed CAR-T cells
  • Shanghai, China
    Shanghai Tongji Hospital, Tongji University School of Medicine
Jul 25, 2019

Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Primary Cutaneous Follicle Centre Lymphoma Trial in Hefei (Autologous

Unknown status
  • Diffuse Large B Cell Lymphoma
  • +6 more
  • Autologous chimeric antigen receptor T cell transfusing agent targeting CD22
  • Hefei, Anhui, China
    PersonGen·Anke cellular therapeutics Co., Ltd
Jun 25, 2019

Acute Lymphoblastic Leukemia, B Cell Lymphoma Trial in Wuhan (Second generation CAR-T cells)

Unknown status
  • Acute Lymphoblastic Leukemia
  • B Cell Lymphoma
  • Second generation CAR-T cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
May 8, 2019

Acute Lymphoblastic Leukemia, B Cell Lymphoma Trial in Wuhan (Allogeneic hematological stem cell transplantation)

Unknown status
  • Acute Lymphoblastic Leukemia
  • B Cell Lymphoma
  • Allogeneic hematological stem cell transplantation
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
May 8, 2019

Refractory, Relapsed, B Cell Lymphoma Trial in Zhengzhou (CAR-T cells)

Unknown status
  • Refractory
  • +3 more
  • CAR-T cells
  • Zhengzhou, Henan, China
  • +1 more
Mar 19, 2019

B Cell Lymphoma Trial in Hangzhou (CAR-T)

Unknown status
  • B Cell Lymphoma
  • CAR-T
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of Zhejiang University
Feb 13, 2019

Acute Lymphoblastic Leukemia, B Cell Lymphoma Trial in Wuhan (Second generation CAR-T cells, Hematological stem cell

Unknown status
  • Acute Lymphoblastic Leukemia
  • B Cell Lymphoma
  • Second generation CAR-T cells
  • Hematological stem cell transplantation
  • Wuhan, Hubei, China
    Institute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2018

B Cell Lymphoma Trial in France (Rituximab -CHOP plus Velcade)

Completed
  • B Cell Lymphoma
  • Rituximab -CHOP plus Velcade
  • Paris, Paris 10, France
  • +3 more
Aug 21, 2018

B Cell Leukemia, B Cell Lymphoma Trial in Weifang (ICAR19 CAR-T cells)

Recruiting
  • B Cell Leukemia
  • B Cell Lymphoma
  • ICAR19 CAR-T cells
  • Weifang, Shandong, China
    Weifang People's Hospital
Dec 19, 2017

B Cell Lymphoma, B Cell Leukemia Trial in Uppsala (Autologous 3rd generation CD19-targeting CAR T cells)

Completed
  • B Cell Lymphoma
  • B Cell Leukemia
  • Autologous 3rd generation CD19-targeting CAR T cells
  • Uppsala, Sweden
    Uppsala University Hospital, Dept of Oncology
Oct 27, 2017

B Cell Lymphoma, Follicular Lymphoma, Lymphoma Trial run by the NCI (Id-KLH Vaccine, GM-CSF)

Completed
  • B Cell Lymphoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

B Cell Lymphoma, Follicular Lymphoma, Tumor Trial run by the NCI (Id-KLH Vaccine, QS-21 (Stimulation-QS-21) Drug)

Completed
  • B Cell Lymphoma
  • +2 more
  • Id-KLH Vaccine
  • QS-21 (Stimulation-QS-21) Drug
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

B Cell Lymphoma Trial in Shenzhen (Fludarabine, Cyclophosphamide, CD19 CART)

Unknown status
  • B Cell Lymphoma
  • Shenzhen, Guangdong, China
    The Second People's Hospital of Shenzhen
May 16, 2017

B Cell Lymphoma Trial in Zhengzhou (Cyclophosphamide, Fludarabine, CART-19)

Unknown status
  • B Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Apr 4, 2017

B Cell Lymphoma Trial in Rennes (rituximab, doxorubicin, vincristine)

Terminated
  • B Cell Lymphoma
  • Rennes, France
    Regional university hospital
Feb 20, 2017

Solid Tumors, B Cell Lymphoma Trial in Beijing (Decitabine, cytokine-induced killer cell)

Unknown status
  • Solid Tumors
  • B Cell Lymphoma
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Jan 26, 2016

Mantle Cell Lymphoma, B Cell Lymphoma, Multiple Myeloma Trial in New Brunswick (Canfosfamide HCl for injection)

Completed
  • Mantle Cell Lymphoma
  • +2 more
  • Canfosfamide HCl for injection
  • New Brunswick, New Jersey
    Cancer Institute of New Jersey
Mar 13, 2013

Lymphoma, Malignant, Hodgkin's Lymphoma, B Cell Lymphoma Trial in Houston (SB1518)

Completed
  • Lymphoma, Malignant
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Apr 19, 2012

B Cell Lymphoma, T Cell Lymphoma Trial in Las Vegas (Poly-ICLC)

Terminated
  • B Cell Lymphoma
  • T Cell Lymphoma
  • Las Vegas, Nevada
    Nevada Cancer Institute
Jul 19, 2011

B Cell Lymphoma Trial run by the NCI (IgG-RFB4-SMPT-dgA)

Completed
  • B Cell Lymphoma
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008